BR Biopharma, Inc. (NASDAQ:BRBI) Sees Large Growth in Short Interest

BR Biopharma, Inc. (NASDAQ:BRBI) was the target of a large growth in short interest during the month of October. As of October 30th, there was short interest totaling 13,657 shares, a growth of 1,264.3% from the October 15th total of 1,001 shares. Based on an average daily volume of 6,646 shares, the short-interest ratio is currently 2.1 days. Currently, 0.1% of the company’s shares are sold short.

BR Biopharma Stock Up 25.5%

NASDAQ BRBI traded up $1.86 during trading on Tuesday, reaching $9.18. 327 shares of the stock traded hands, compared to its average volume of 5,049. BR Biopharma has a fifty-two week low of $6.87 and a fifty-two week high of $16.61. The stock’s 50-day moving average price is $11.43 and its 200 day moving average price is $12.52.

BR Biopharma (NASDAQ:BRBI) last posted its earnings results on Tuesday, November 3rd. The company reported $0.05 earnings per share for the quarter. The firm had revenue of $23.80 million during the quarter.

BR Biopharma Cuts Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 4th. Investors of record on Monday, November 16th will be given a $0.0879 dividend. The ex-dividend date is Monday, November 16th. This represents a $0.35 dividend on an annualized basis and a dividend yield of 3.8%. This is a decrease from BR Biopharma’s previous quarterly dividend of $0.1415. BR Biopharma’s dividend payout ratio is currently 525.00%.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on BRBI shares. Weiss Ratings raised BR Biopharma from a “sell (d-)” rating to a “sell (d)” rating in a research note on Friday, October 2nd. Citigroup lowered BR Biopharma from a “buy” rating to a “hold” rating in a research note on Tuesday, October 27th. One equities research analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Reduce”.

About BR Biopharma

BRBI BR Partners S.A., through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners S.A. is based in S?o Paulo, Brazil.